Erythromycin ethylsuccinate 40 mg/ML / sulfisoxazole 120 mg/ML Oral Suspension [Eryzole]
RxNorm 686389
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 686389 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: erythromycin ethylsuccinate 40 mg/ML / sulfisoxazole 120 mg/ML Oral Suspension [Eryzole].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SY
Synonym (SY):
EES 40 mg/ML / Sulfisoxazole 120 mg/ML Oral Suspension [Eryzole]
(Atom ID: 3855912)
TMSY
Tall Man Lettering Synonym (TMSY):
EES 40 mg/ML / sulfiSOXAZOLE 120 mg/ML Oral Suspension [Eryzole]
(Atom ID: 3859081)
SBD
Semantic Branded Drug (SBD):
Erythromycin ethylsuccinate 40 mg/ML / sulfisoxazole 120 mg/ML Oral Suspension [Eryzole]
(Atom ID: 12357730)
TMSY
Tall Man Lettering Synonym (TMSY):
Erythromycin ethylsuccinate 40 mg/ML / sulfiSOXAZOLE 120 mg/ML Oral Suspension [Eryzole]
(Atom ID: 12381566)
SY
Synonym (SY):
Eryzole (erythromycin ethylsuccinate 200 mg / sulfisoxazole 600 mg) per 5 mL Powder for Oral Suspension
(Atom ID: 3803754)
TMSY